A prospective crossover trial of botulinum toxin chemodenervation versus injection augmentation for essential voice tremor
The Laryngoscope Oct 12, 2017
Estes C, et al. - The goal of this paper was to discern the comparative utility of injection augmentation (IA) for essential voice tremor (EVT). No advantage was unveiled by the IA demonstrated over botulinum toxin chemodenervation (BTX) in the treatment of EVT.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
